A glance at G-protein-coupled receptors for lipid mediators: a growing receptor family with remarkably diverse ligands

被引:52
作者
Kostenis, E [1 ]
机构
[1] 7TM Pharma AS, DK-2970 Horsholm, Denmark
关键词
GPCR; sphingosine-1-phosphate; lysophosphatidic acid; sphingosylphosphorycholine; phosphatidic acid; lipid receptor;
D O I
10.1016/j.pharmthera.2004.04.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A plethora of lipid-like molecules known to act as intracellular second messengers are now recognized to signal cells through plasma membrane 7 transmembrane G-protein-coupled receptors (GPCRs). This has been the result of a decade-long genetic hunt for novel sequences encoding 7 transmembrane receptor proteins and the efforts to pair novel sequences with biologically active substances of (partly) unknown molecular mechanism of action. Identification of novel GPCR ligand pairs represents the first step to shed more light into the mode of action of novel cellular signaling molecules in human health and disease and might, represent a fruitful source for the development of new drugs, judged on the successful history of GPCR as drug targets. Since 2000, more than 16 reports became available on lipid mediators-as diverse as lysophospholipids, arachidonic acid metabolites, short-, medium-, and long-chain fatty acids as well as steroid-like molecules-exerting their effects as extracellular mediators via rhodopsin-like family GPCRs. These reports have opened new avenues for research in human lipid receptor physiology and pharmacology. Here, the current knowledge on the recently deorphanized lipid receptors, including their isolation, expression pattern, function, and possible physiological or pathological roles will be reviewed. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:243 / 257
页数:15
相关论文
共 162 条
[11]  
Brossard N, 1997, J LIPID RES, V38, P1571
[12]   The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids [J].
Brown, AJ ;
Goldsworthy, SM ;
Barnes, AA ;
Eilert, MM ;
Tcheang, L ;
Daniels, D ;
Muir, AI ;
Wigglesworth, MJ ;
Kinghorn, I ;
Fraser, NJ ;
Pike, NB ;
Strum, JC ;
Steplewski, KM ;
Murdock, PR ;
Holder, JC ;
Marshall, FH ;
Szekeres, PG ;
Wilson, S ;
Ignar, DM ;
Foord, SM ;
Wise, A ;
Dowell, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (13) :11312-11319
[13]   Regulation of glucagon-like peptide-1 synthesis and secretion in the GLUTag enteroendocrine cell line [J].
Brubaker, PL ;
Schloos, J ;
Drucker, DJ .
ENDOCRINOLOGY, 1998, 139 (10) :4108-4114
[14]   PROPIONATE INDUCES POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION AND INHIBITS FORMYLMETHIONYL-LEUCYL-PHENYLALANINE-STIMULATED ACTIVATION [J].
BRUNKHORST, BA ;
KRAUS, E ;
COPPI, M ;
BUDNICK, M ;
NIEDERMAN, R .
INFECTION AND IMMUNITY, 1992, 60 (07) :2957-2968
[15]   A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine 1-phosphate in atrial myocytes [J].
Bunemann, M ;
Liliom, K ;
Brandts, BK ;
Pott, L ;
Tseng, JL ;
Desiderio, DM ;
Sun, GP ;
Miller, D ;
Tigyi, G .
EMBO JOURNAL, 1996, 15 (20) :5527-5534
[16]   Pituitary adenylate cyclase-activating polypeptide stimulates cholecystokinin secretion in STC-1 cells [J].
Chang, CH ;
Chey, WY ;
Braggins, L ;
Coy, DH ;
Chang, TM .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1996, 271 (03) :G516-G523
[17]   International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature [J].
Chun, J ;
Goetzl, EJ ;
Hla, T ;
Igarashi, Y ;
Lynch, KR ;
Moolenaar, W ;
Pyne, S ;
Tigyi, G .
PHARMACOLOGICAL REVIEWS, 2002, 54 (02) :265-269
[18]   Selective deletion of leptin receptor in neurons leads to obesity [J].
Cohen, P ;
Zhao, C ;
Cai, XL ;
Montez, JM ;
Rohani, SC ;
Feinstein, P ;
Mombaerts, P ;
Friedman, JM .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (08) :1113-1121
[19]   Requirement for the IpA1 lysophosphatidic acid receptor gene in normal suckling behavior [J].
Contos, JJA ;
Fukushima, N ;
Weiner, JA ;
Kaushal, D ;
Chun, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (24) :13384-13389
[20]   Characterization of lpa2 (Edg4) and lpa1/lpa2 (Edg2/Edg4) lysophosphatidic acid receptor knockout mice:: Signaling deficits without obvious phenotypic abnormality attributable to lpa2 [J].
Contos, JJA ;
Ishii, I ;
Fukushima, N ;
Kingsbury, MA ;
Ye, XQ ;
Kawamura, S ;
Brown, JH ;
Chun, J .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (19) :6921-6929